Skip to main content

Table 3 The effect of Bestatin on survival time of nude mice

From: Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells

Cells

Control-group

Bestatin-group

HRA

13.8 ± 0.8

15.8 ± 2.5

SKOV-3

29.0 ± 3.0

*36.1 ± 6.5 (days)

  1. Mean survival days of PBS alone or bestatin treated mice with innoculation of 1.0 × 107 HRA and SKOV-3 cells, respectively. Data are expressed as the mean ± SD. *; p < 0.05